NewsBenzingaMilestone Pharmaceuticals Announces Cost-Efficiency Measures To Reduce Its Opex By ~30%, Completed By Q1 2027; Expects To Incur ~$2M In One-Time Charges Milestone Pharmaceuticals Announces Cost-Efficiency Measures To Reduce Its Opex By ~30%, Completed By Q1 2027; Expects To Incur ~$2M In One-Time Charges Benzinga 2026.11.13 12:13 (GMT+0) Open on Benzinga Other news Jensen Huang Faces Subpoena Threat As 3 Republican-Led House Committees Demand Closed-Door Testimony Over Nvidia’s China Ties Sigma Lithium Q3 EPS $(0.23), Sales $13.522M Columbia Banking System Board Raises Quarterly Cash Dividend From $0.37 To $0.38 Per Share Piper Sandler Upgrades Americold Realty Trust to Overweight, Raises Price Target to $19 Piper Sandler Downgrades Hancock Whitney to Neutral, Lowers Price Target to $71.5 Rosenblatt Maintains Buy on Cisco Systems, Lowers Price Target to $140
Jensen Huang Faces Subpoena Threat As 3 Republican-Led House Committees Demand Closed-Door Testimony Over Nvidia’s China Ties
